Novartis Ag (NVS) Change in Cash (2009 - 2025)

Novartis Ag (NVS) has 15 years of Change in Cash data on file, last reported at -$792.0 million in Q2 2025.

• Quarterly Change in Cash rose 48.3% year-over-year to -$792.0 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$2.1 billion (up 80.96% YoY) and the FY2025 annual result came in at -$600.0 million, up 68.98% from the prior year.
• Change in Cash climbed to -$792.0 million in Q2 2025 per NVS's latest filing, from -$5.3 billion in the prior quarter.
• The five-year high for Change in Cash was $5.5 billion in Q3 2024, with the low at -$10.2 billion in Q2 2022.
• Average Change in Cash over 5 years is -$2.5 billion, with a median of -$1.3 billion recorded in 2023.
• Year-over-year, Change in Cash soared 102.07% in 2023 and plunged 3061.11% in 2024.
• Novartis Ag's Change in Cash stood at -$4.3 billion in 2021, then sank by 100.21% to -$8.7 billion in 2022, then soared by 102.07% to $180.0 million in 2023, then sank by 3061.11% to -$5.3 billion in 2024, then surged by 85.14% to -$792.0 million in 2025.
• Business Quant data shows NVS's Change in Cash at -$792.0 million in Q2 2025, -$5.3 billion in Q4 2024, and $5.5 billion in Q3 2024.